GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Other Current Payables

CLDI (Calidi Biotherapeutics) Other Current Payables : $0.64 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Other Current Payables?

Calidi Biotherapeutics's Other Current Payables for the quarter that ended in Dec. 2024 was $0.64 Mil.

Calidi Biotherapeutics's quarterly Other Current Payables increased from Jun. 2024 ($0.09 Mil) to Sep. 2024 ($0.62 Mil) and increased from Sep. 2024 ($0.62 Mil) to Dec. 2024 ($0.64 Mil).

Calidi Biotherapeutics's annual Other Current Payables declined from Dec. 2022 ($0.15 Mil) to Dec. 2023 ($0.08 Mil) but then increased from Dec. 2023 ($0.08 Mil) to Dec. 2024 ($0.64 Mil).

Calidi Biotherapeutics Other Current Payables Historical Data

The historical data trend for Calidi Biotherapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Other Current Payables Chart

Calidi Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Payables
0.15 0.11 0.15 0.08 0.64

Calidi Biotherapeutics Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.09 0.09 0.62 0.64

Calidi Biotherapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Calidi Biotherapeutics Other Current Payables Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Other Current Payables
Comparable Companies
INAB AFMD ABVC PHGE BIVI EQ MBRX BOLT ZEOX SABS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
4475 Executive Drive, Suite 200, San Diego, CA, USA, 92121
Website
https://www.calidibio.com
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.